US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines


Modified 20 Feb 2021, 5:19 am

The two Covid-19 vaccines approved for use in the United States have reassuring safety profiles with no concerning new issues found in data collected from the first month of vaccinations, the US Centers for Disease Control and Prevention (CDC) said on Friday.

After administration of 13.8 million doses of the Pfizer/ BioNTech and Moderna Inc vaccines to the US population, most reports indicated non-serious side effects of the type that had been expected, such as headaches and fatigue. No deaths have been attributed to the vaccines, the data showed...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In